will all be heros here.
that's probably it.
The StreetInsider From 5/6/13
Article ---Jefferies Maintains Bullish Stance on Acadia Pharmaceuticals (ACAD) after Management Meetings
"We had an opportunity to meet with ACAD management recently and are incrementally encouraged bycommentary on manufacturing timelines for pimavanserin, the rate limiting step to filing, as well as commentary on outside interest in pimavanserin from pharma companies,"